Take the Mundane Out of Your Meetings: Cisco Enhances Webex to Include More of What You Do Every Day to Get Great Work Done
PHOENIX, April 18, 2018 (GLOBE NEWSWIRE) -- "Let's talk about it-I'll set up a Webex!" Ever heard (or said) that sentence? If you are like most workers, the answer is yes; the name "Webex" is synonymous with the word "meet". It is the gold standard when it comes to real-time meetings and getting things done. More than six billion meeting minutes happen in Cisco® Webex ® every month.
But the way people meet is changing. And Webex is ready.
To make it easier for teams to meet and get great work done, today we announce that we are converging the Cisco Spark(TM) and Webex platforms. The result is a new Webex Meetings application for your meetings and a new seamless team collaboration application called Webex Teams (formerly Cisco Spark). We are putting all our award-winning video devices onto this newly converged platform. And we're adding a new hardware device that turns any work space with a TV into a Webex room. We didn't stop there. We're making everything easier to buy. And we're continuing to apply machine learning and artificial intelligence that will dramatically improve meetings as we know them today.
Here's more information about each part of our news:
We launch an all-new version of Webex meetings.
The first thing you will notice about the new Webex Meetings is that it is "video first," meaning you'll be strongly encouraged to turn on your camera. That's because seeing and being seen are fundamental to good teamwork. Gone are the days when you'd stare at the screen only to see the presentation. You'll now see all your teammates, in crisp, clean layouts whether you are using your laptop, your Cisco video room device or your mobile device.
Because we deliver Webex through the cloud, the one hundred million people worldwide who use Webex do not need to take any action. They will simply get the update in the coming months.
We launch a brand new version of Cisco Spark and at the same time give it a new name
Today's business challenges are getting more and more complex, creating an urgency to help teams connect and get their best work done. We want to make it simple for our Webex users to take the next step to team collaboration.
Our goal has always been to make Cisco Spark the simplest, most secure team collaboration tool on the planet. Today, we launch a new version of Cisco Spark, and give it a new name: Webex Teams. Now, when companies are ready to make their move to team collaboration they can do so with the brand that they already know and love-Webex. All they need to do is add the Teams extension to start using team-based persistent collaboration.
With this new version, we have completely integrated the technology across the applications-so you can expect the same rich Webex meeting functionality in Teams meetings, and a common experience no matter which you choose. Webex Teams gives you a much richer set of tools-including whiteboarding, persistent messaging, simple guest access, content sharing and integrated tools-to support teams both during and after the meeting.
The new name also extends to our award-winning devices. For instance, the Cisco Spark Board becomes the Webex Board. That's because Webex meetings are even better when you join from one of Cisco's video devices.
We announce a new device that turns any space with a TV into a Webex room.
While visiting customers we noticed that many huddle spaces-most, even-have a little-used TV hanging on the wall. What if we could enlist these TVs to make team huddles better? we asked.
Out of that question came Webex Share(TM), a low-cost, super-simple way for teams to share content on the big screen in the space. Simply plug the palm-sized adapter into the back of the TV. Pair with the system, and start sharing your document or screen. When you're done, keep the work going in your Webex Teams space. Plus, with Webex Share, teams will be able to easily reserve rooms, know when a room is already booked, and much more.
Webex Share will be available for Webex Meetings and Teams towards the end of 2018.
We share an all-new roadmap for how Webex will work with tools from Google, Microsoft, and other companies.
We believe in choice. We want our customers to be free to choose whichever tool is right for them. Want to use Webex for meetings but Microsoft for team collaboration? No problem. With the new Webex you can do just that. We'll work with Google, Slack and others, too. It's important our customers have choices, and therefore it is important to us to make it easier for them.
We make buying great tools for your team easy.
Buying should be simple and with the Cisco Collaboration Flex Plan, it is. As of today, companies can simply pay a subscription fee for each active user. And with Webex Meetings, now up to 1,000 people can join and we have added more storage, advanced security and analytics capabilities.
We put artificial intelligence (AI) to work to end lousy meetings.
In November, we announced our plans to use AI to make meetings better. Today we build upon that in two ways:
Webex Assistant(TM) (formerly Cisco Spark Assistant ) will be available on more devices and with more functionality. We continue the journey to inject AI into every meeting, every call, every conversation and every interaction that you have. Based on technology from our MindMeld acquisition, Webex Assistant will start showing up over the next couple of months in all our cloud-connected Webex Room Kit and Room Series devices.
Noise suppression saves the call. The loud typist. The barking dog. The side conversation. These are just a few of the annoyances that disrupt many meetings. But not anymore: all Cisco cloud-connected and on-premise video devices can now suppress disruptive noises. This means the next time someone starts loudly shuffling papers on a call, the system will automatically turn the volume down enough so that the sound no longer interrupts the conversation. And when the paper shuffler chimes in with a comment, the system will "know" that and automatically stop suppressing the sound. To the user, it's magic: no need to do a thing.
"Everything we do is designed with people in mind-to help them work, collaborate, and create together. That's why we have invested so much in Webex," said Rowan Trollope, SVP and GM, Applications Group, Cisco. "Our vision is to bring this amazing experience to a billion users and conference rooms all around the world."
- Watch the Collaboration Summit keynote live today at 9 am Pacific.
- Read Jonathan Rosenberg's blog on our platform convergence news.
- Read Snorre Kjesbu's blog on Webex Share.
Cisco (NASDAQ:CSCO) powers the world's Internet experiences. We securely connect people, processes, data and things to enable innovation that benefits business and society. For more information, visit: http://thenetwork.cisco.com.
Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.
Availability Disclaimer: Many of the products and features described herein remain in varying stages of development and will be offered on a when-and-if-available basis. These products and features are subject to change at the sole discretion of Cisco, and Cisco will have no liability for delay in the delivery or failure to deliver any of the products or features set forth in this document.
Photos accompanying this announcement are available at
+1 (617) 595-8434
Industry Analyst Contact:
+1 (949) 823 3787
Investor Relations Contact:
+1 (650) 714-9380
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress25.5.2018 07:45 | Pressmeddelande
CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?" The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascular disease, especially in patients with diabetes mellitus, and the significant unmet need that still exists in this patient population. The symposium is co-chaired by Vincent M. Brandenburg, MD - Nephrologist, Aachen, Germany and Kamyar Kalantar-Zadeh, MD - UC Irvine School of Medicine, Irvine, CA, USA, both leading scientists also serving as advisors to Resverlogix's Renal program. The speakers and agenda are as follows: Introduction Vincent M. Brandenburg, MD - University Hospital of the RWTH
Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30 | Pressmeddelande
(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional
Elemica Reports Double Digit Network Growth and Announces New Product Innovations in First Quarter 201824.5.2018 18:18 | Pressmeddelande
Helping Process Manufacturers Undergo Digital Transformation Leads to Introduction of New Transformative Solutions WAYNE, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Elemica, the leading Digital Supply Network for process manufacturing industries, announces the company's first quarter results of 2018 highlighting substantial network growth and new product innovations. The Elemica Digital Supply Network had significant network expansion in the first quarter with traffic growing 10 percent year-over-year in Q1. Shipment traffic grew substantially based on new product expansions of Elemica Trace. "Elemica's growth can be attributed to our clients needing our expertise and technology to undergo a Digital Transformation that connects, automates, anticipates and transforms their enterprise for their business growth initiatives," said John Blyzinskyj, CEO of Elemica. "Our digital supply network enables businesses to grow their top and bottom lines, mitigate risk and improve customer satisfaction ac
Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16 | Pressmeddelande
London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h
SEMAFO Signs Underground Mining Services Contract with AUMS24.5.2018 14:00 | Pressmeddelande
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) reports that it has signed a mining services contract with African Underground Mining Services ("AUMS") to provide turnkey mining services for Siou underground. AUMS is a well-known and reputable mining contractor with underground experience in Burkina Faso and across Africa. Under the mining services contract, AUMS will be responsible for supplying the mining fleet and a skilled labour force for Siou underground in addition to ensuring development, production and auxiliary services. SEMAFO will provide technical services including geology and engineering as well as leveraging the existing surface infrastructure at Mana. The mining services contract has a term of 70 months. The economic terms of the mining services contract are consistent with the economics presented in the Mana pre-feasibility study filed March 29, 2018 on SEDAR. Preparatory work has already commenced on Siou underground with full project deplo
Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors24.5.2018 13:00 | Pressmeddelande
- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient has been dosed in a Phase 1, first-in human clinical trial of MCLA-158 in patients with solid tumors with an initial focus on metastatic colorectal cancer. The trial will be conducted in Europe, where several Clinical Trial Applications (CTAs) have been approved to date. The Company also announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for MCLA-158, which was accepted by the FDA in April 2018. With this acceptance, Merus plans to open additional sites for this trial in the United States. MCLA-158 is designed to bind to cancer stem cells expressing leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) and epidermal grow
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum